GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

BACKGROUND: Glypican 3 (GPC3) is a heparin sulphate proteoglycan whose expression is associated with several malignancies. However, its expression in non-small-cell lung carcinoma (NSCLC) is limited and ambiguous. This study aimed to comprehensively evaluate the expression of GPC3 in NSCLC and devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Jing, Jiang, Shenyi, Li, Xiaoxi, Wang, Yang, Deng, Xuhong, Zhang, Zhiqiang, He, Lijie, Wang, Daqing, Jiang, Youhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194200/
https://www.ncbi.nlm.nih.gov/pubmed/34112123
http://dx.doi.org/10.1186/s12890-021-01549-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194200/
https://www.ncbi.nlm.nih.gov/pubmed/34112123
http://dx.doi.org/10.1186/s12890-021-01549-9

Ejemplares similares